In summary, our study suggests that TRIM32 plays a significant role in promoting cell proliferation, invasion and tumorigenesis thus bringing about an undesirable outcome among patients with GC by up‐regulating the β‐catenin signalling pathway. The gene discussed is TRIM32; the disease is gastric cancer.